SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 22 Jun 2021
Last Applicant/ Owned by
9393 Towne Centre Drive
San Diego
CA
92121
Serial Number
86363098 filed on 11th Aug 2014
Registration Number
4712007 registered on 31st Mar 2015
Correspondent Address
Marilyn F. Kelly
Marilyn F. Kelly Bristol-Myers Squibb Company
Trademark Dept., Mailstop D.4243
Princeton, NJ 08648-4000
United States
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
MIRATI
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology
Classification Information
Class [042]
Computer & Software Services & Scientific Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology
First Use Date in General
30th Apr 2013
First Use Date in Commerce
30th Apr 2013
Mark Details
Serial Number
No 86363098
Mark Type
No Service Mark
Attorney Docket Number
No 00163770-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 25th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 25th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 31st Mar 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 22nd Jun 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 22nd Jun 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 21st Jun 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Feb 2021 | TEAS SECTION 8 & 15 RECEIVED |
| 31st Mar 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 04th Feb 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |